Several pieces of evidence have established that CaMKII has a central role in regulating inflammation in myocardial infarction (MI), since it is oxidized as a consequence of increased β-adrenergic activation upon MI, which is followed by increased intracellular ROS [88,89]. Here, CAMK2G is linked to myocardial infarction.